1. Home
  2. AMRX vs HUN Comparison

AMRX vs HUN Comparison

Compare AMRX & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • HUN
  • Stock Information
  • Founded
  • AMRX 2002
  • HUN 1970
  • Country
  • AMRX United States
  • HUN United States
  • Employees
  • AMRX N/A
  • HUN N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • HUN Major Chemicals
  • Sector
  • AMRX Health Care
  • HUN Industrials
  • Exchange
  • AMRX Nasdaq
  • HUN Nasdaq
  • Market Cap
  • AMRX 2.5B
  • HUN 2.4B
  • IPO Year
  • AMRX N/A
  • HUN 2005
  • Fundamental
  • Price
  • AMRX $8.37
  • HUN $11.31
  • Analyst Decision
  • AMRX Strong Buy
  • HUN Hold
  • Analyst Count
  • AMRX 4
  • HUN 9
  • Target Price
  • AMRX $11.50
  • HUN $15.00
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • HUN 3.7M
  • Earning Date
  • AMRX 08-08-2025
  • HUN 08-04-2025
  • Dividend Yield
  • AMRX N/A
  • HUN 8.84%
  • EPS Growth
  • AMRX N/A
  • HUN N/A
  • EPS
  • AMRX N/A
  • HUN N/A
  • Revenue
  • AMRX $2,830,186,000.00
  • HUN $5,976,000,000.00
  • Revenue This Year
  • AMRX $9.84
  • HUN N/A
  • Revenue Next Year
  • AMRX $7.33
  • HUN $5.10
  • P/E Ratio
  • AMRX N/A
  • HUN N/A
  • Revenue Growth
  • AMRX 13.42
  • HUN 0.02
  • 52 Week Low
  • AMRX $6.32
  • HUN $10.13
  • 52 Week High
  • AMRX $9.48
  • HUN $25.12
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 65.61
  • HUN 52.03
  • Support Level
  • AMRX $8.05
  • HUN $10.30
  • Resistance Level
  • AMRX $8.24
  • HUN $10.69
  • Average True Range (ATR)
  • AMRX 0.23
  • HUN 0.42
  • MACD
  • AMRX 0.04
  • HUN 0.10
  • Stochastic Oscillator
  • AMRX 93.15
  • HUN 63.78

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: